DE602005015754D1 - Neue multimere cd40-liganden, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln - Google Patents

Neue multimere cd40-liganden, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln

Info

Publication number
DE602005015754D1
DE602005015754D1 DE602005015754T DE602005015754T DE602005015754D1 DE 602005015754 D1 DE602005015754 D1 DE 602005015754D1 DE 602005015754 T DE602005015754 T DE 602005015754T DE 602005015754 T DE602005015754 T DE 602005015754T DE 602005015754 D1 DE602005015754 D1 DE 602005015754D1
Authority
DE
Germany
Prior art keywords
residues
amino acid
medicaments
ligands
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015754T
Other languages
English (en)
Inventor
Gilles Guichard
Sylvie Victorine Fournel
Olivier Chaloin
Nathalie Trouche
Sebastien Wieckowski
Johan Hoebeke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602005015754D1 publication Critical patent/DE602005015754D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE602005015754T 2004-12-15 2005-12-15 Neue multimere cd40-liganden, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln Active DE602005015754D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0413331A FR2879202B1 (fr) 2004-12-15 2004-12-15 Nouveaux ligands multimeriques de cd40, leur procede de preparation et leur utilisation pour la preparation de medicaments
PCT/FR2005/003146 WO2006064133A2 (fr) 2004-12-15 2005-12-15 Nouveaux ligands multimeriques de cd40, leur procede de preparation et leur utilisation pour la preparation de medicaments

Publications (1)

Publication Number Publication Date
DE602005015754D1 true DE602005015754D1 (de) 2009-09-10

Family

ID=34953347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015754T Active DE602005015754D1 (de) 2004-12-15 2005-12-15 Neue multimere cd40-liganden, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln

Country Status (9)

Country Link
US (1) US8357654B2 (de)
EP (1) EP1828240B1 (de)
JP (1) JP5039561B2 (de)
AT (1) ATE437890T1 (de)
CA (1) CA2591035A1 (de)
DE (1) DE602005015754D1 (de)
ES (1) ES2331321T3 (de)
FR (1) FR2879202B1 (de)
WO (1) WO2006064133A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108976147B (zh) * 2017-05-31 2021-02-12 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰碱性氨基酸，其合成，活性和应用
WO2018234455A1 (en) * 2017-06-21 2018-12-27 Xl-Protein Gmbh CONJUGATES OF PROTEIN MEDICINAL PRODUCTS AND PEPTIDES M / S
KR102389725B1 (ko) * 2020-02-14 2022-04-25 서울대학교산학협력단 피페라진산을 함유하는 사이클릭 펩티드 화합물, 이의 생산 방법, 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511569A (ja) * 1998-04-14 2002-04-16 スミスクライン・ビーチャム・コーポレイション 受容体リガンド
DE19963859A1 (de) * 1999-12-30 2001-07-12 Apotech Res & Dev Ltd Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen
GB0015426D0 (en) * 2000-06-24 2000-08-16 Univ Southampton Method for generating soluble highly multimeric proteins
FR2840307B1 (fr) 2002-05-30 2006-07-07 Centre Nat Rech Scient Nouvelles molecules multimeriques, leur procede de preparation, et leur utilisation pour la preparation de medicaments

Also Published As

Publication number Publication date
US20100183642A1 (en) 2010-07-22
WO2006064133A3 (fr) 2006-08-31
JP5039561B2 (ja) 2012-10-03
EP1828240A2 (de) 2007-09-05
ES2331321T3 (es) 2009-12-29
WO2006064133A2 (fr) 2006-06-22
FR2879202A1 (fr) 2006-06-16
ATE437890T1 (de) 2009-08-15
US8357654B2 (en) 2013-01-22
FR2879202B1 (fr) 2007-02-23
JP2008524173A (ja) 2008-07-10
EP1828240B1 (de) 2009-07-29
CA2591035A1 (fr) 2006-06-22

Similar Documents

Publication Publication Date Title
TW458986B (en) Novel thrombin inhibitors, and the salts thereof with physiologically tolerated acids and the stereoisomers thereof
UA93669C2 (ru) Способ приготовления полипептидной смеси c использованием гидрогенолиза
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
MXPA04000559A (es) Sistema catalizador que contiene ni (o).
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
ATE466867T1 (de) Neue topisch anwendbare wirkstoffe gegen mimische und alterabedingt falten
DE602007008616D1 (de) Verfahren zur herstellung von 4'-azidocytidinderivaten
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
SE9903291D0 (sv) New process
DE50308114D1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen
ATE367815T1 (de) Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
DE602005015754D1 (de) Neue multimere cd40-liganden, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
EP1147123A4 (de) Neuartige geruchsrezeptoren in drosophila
WO2003102207A3 (fr) Nouvelles molecules multimeriques, leur procede de preparation, et leur utilisation pour la preparation de medicaments
ATE297428T1 (de) Modifizierte polyamide, zusammensetzungen auf basis dieser polyamide und verfahren zu ihrer herstellung
TW200502238A (en) Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
ATE533776T1 (de) Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung
HUP0301396A2 (hu) Integrin inhibitor hatású peptid- és peptidutánzó konjugátumok, azokat tartalmazó implantátumok és alkalmazásuk
DE60324970D1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE50304242D1 (de) Verfahren zur herstellung von acylphosphinoxiden
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
DE69917615D1 (de) Ein verfahren zur herstellung von (2s,2'r,3'r)-2-(2,3-dicarboxycyclopropyl)-glycin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition